Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 825 of 1294 entries
View as:

Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00104182 Org: User:
Start: 02/28/05 End: 02/28/06 Due: 02/28/07

A Study to Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and Poland

Phase: N/A Priority: Normal
NCT ID: NCT05795166 Org: User:
Start: 04/27/23 End: 11/30/23 Due: 11/30/24

A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT05365217 Org: User:
Start: 05/18/22 End: 05/11/24 Due: 05/11/25

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04559815 Org: User:
Start: 10/21/20 End: 09/07/22 Due: 09/07/23

A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04042441 Org: User:
Start: 07/29/19 End: 12/11/20 Due: 12/11/21

Patient Preference Study in Type-2 Diabetes Mellitus: Discrete Choice Experiment (DCE) to Support Novo Nordisk's Long-Acting Insulin

Phase: N/A Priority: Normal
NCT ID: NCT06592950 Org: User:
Start: 11/02/23 End: 04/29/24 Due: 04/29/25

Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy Women

Phase: N/A Priority: Normal
NCT ID: NCT01596010 Org: User:
Start: 10/31/07 End: 11/30/07 Due: 11/30/08

A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06340854 Org: User:
Start: 04/19/24 End: 06/20/25 Due: 06/20/26

A Research Study, Looking at the Characterization of Treatment Intensified (Add on to Metformin) Real-world Adult Population With Type 2 Diabetes Mellitus in India, Pakistan and Thailand.

Phase: N/A Priority: Normal
NCT ID: NCT05542420 Org: User:
Start: 10/19/22 End: 04/20/23 Due: 04/20/24

A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese

Phase: N/A Priority: Normal
NCT ID: NCT03574584 Org: User:
Start: 06/18/18 End: 07/27/19 Due: 07/27/20

Awareness, Care & Treatment In Obesity Management

Phase: N/A Priority: Normal
NCT ID: NCT05690789 Org: User:
Start: 09/27/22 End: 03/31/23 Due: 03/31/24

Glycaemic Control and Other Clinical Parameters in Adult Type 2 Diabetes Patients on Basal Insulin Initiating Treatment With IDegLira in Routine Clinical Practice in Colombia

Phase: N/A Priority: Normal
NCT ID: NCT05324462 Org: User:
Start: 03/22/22 End: 07/15/22 Due: 07/15/23

Awareness, Care & Treatment In Obesity Management - An Observation in Mainland China

Phase: N/A Priority: Normal
NCT ID: NCT05428501 Org: User:
Start: 08/18/22 End: 11/30/22 Due: 11/30/23

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT06221969 Org: User:
Start: 01/16/24 End: 04/03/26 Due: 04/03/27

A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT05227196 Org: User:
Start: 02/04/22 End: 08/08/23 Due: 08/08/24

A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight

Phase: N/A Priority: Normal
NCT ID: NCT05813925 Org: User:
Start: 04/03/23 End: 03/07/25 Due: 03/07/26

Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B

Phase: N/A Priority: Normal
NCT ID: NCT01220141 Org: User:
Start: 11/30/10 End: 03/31/15 Due: 03/31/16

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

Phase: N/A Priority: Normal
NCT ID: NCT05567796 Org: User:
Start: 11/01/22 End: 10/19/26 Due: 10/19/27

Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00312156 Org: User:
Start: 08/31/02 End: 08/31/03 Due: 08/31/04

Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles

Phase: N/A Priority: Normal
NCT ID: NCT00871416 Org: User:
Start: 04/09/97 End: 07/18/97 Due: 07/18/98

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

Phase: N/A Priority: Normal
NCT ID: NCT06534411 Org: User:
Start: 11/05/24 End: 07/14/26 Due: 07/14/27

A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04969939 Org: User:
Start: 07/15/21 End: 01/30/23 Due: 01/30/24

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04537624 Org: User:
Start: 08/24/20 End: 05/31/23 Due: 05/31/24

A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01730014 Org: User:
Start: 10/31/12 End: 07/31/13 Due: 07/31/14

Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01487798 Org: User:
Start: 06/30/02 End: 11/30/03 Due: 11/30/04